SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-16-011628
Filing Date
2016-03-28
Accepted
2016-03-28 08:32:47
Documents
96
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2227962z10-k.htm 10-K 1424904
2 EX-21.1 a2227962zex-21_1.htm EX-21.1 3296
3 EX-23.1 a2227962zex-23_1.htm EX-23.1 3625
4 EX-31.1 a2227962zex-31_1.htm EX-31.1 8167
5 EX-31.2 a2227962zex-31_2.htm EX-31.2 8196
6 EX-32.1 a2227962zex-32_1.htm EX-32.1 4518
7 EX-32.2 a2227962zex-32_2.htm EX-32.2 4573
  Complete submission text file 0001047469-16-011628.txt   7010223

Data Files

Seq Description Document Type Size
8 EX-101.INS ontx-20151231.xml EX-101.INS 1473938
9 EX-101.SCH ontx-20151231.xsd EX-101.SCH 76048
10 EX-101.CAL ontx-20151231_cal.xml EX-101.CAL 60788
11 EX-101.DEF ontx-20151231_def.xml EX-101.DEF 219219
12 EX-101.LAB ontx-20151231_lab.xml EX-101.LAB 595052
13 EX-101.PRE ontx-20151231_pre.xml EX-101.PRE 443108
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36020 | Film No.: 161530722
SIC: 2834 Pharmaceutical Preparations